President-elect Donald Trump’s Friday night news dump of health care nominees included the expected naming of Dr. Marty ...
The Federal Drug Administration (FDA) is warning consumers about unapproved semaglutide, a popular weight loss drug ...
U.S. government researchers have found that a widely prescribed asthma drug originally sold by Merck & Co may be linked to ...
As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.
The US company CervoMed announced yesterday that the FDA has granted Orphan Drug Designation to its oral investigational ...
Applied Therapeutics' New Drug Application for a rare metabolic disease was rejected by the Food and Drug Administration, ...
There are currently no available treatment options for any form of frontotemporal dementia that have been approved by the EMA ...
The Food and Drug Administration (FDA) this week authorized a long-delayed clinical trial to test whether smoking marijuana ...
Applied Therapeutics (APLT) announced the FDA has issued a Complete Response Letter for the New Drug Application for govorestat, for ...
(RTTNews) - CervoMed, Inc. (CRVO) announced Wednesday that its oral investigational drug neflamapimod has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the ...